V. Lassmann-Vague

发表

E. Renard, J. Bringer, B. Guerci, 2010 .

Immunogenicity of Long-Term Intraperitoneal Insulin Administration With Implantable Programmable Pumps: Metabolic consequences

D. Raccah, V. Lassmann-Vague, P. Belicar, 1995, Diabetes Care.

Feasibility of Intraperitoneal Insulin Therapy With Programmable Implantable Pumps in IDDM: A multicenter study

E. Renard, B. Guerci, N. Jeandidier, 1995, Diabetes Care.

Silent myocardial ischemia in patients with diabetes: who to screen.

G. Habib, V. Lassmann-Vague, P. Vague, 1999, Diabetes care.

Diabetes and education in the elderly.

V. Lassmann-Vague, D. Tessier, 2007, Diabetes & metabolism.

Clinical Use of Continuous Glucose Clinical Use of Continuous Glucose Monitoring and Ambulatory Glucose Monitoring and Ambulatory Glucose Profile in Type 1 Diabetes Patients on Profile in Type 1 Diabetes Patients on Multiple Daily Injections Multiple Daily Injections

D. Owens, E. Renard, M. Massi-Benedetti, 2014 .

Hypoglycaemia in elderly diabetic patients.

V. Lassmann-Vague, 2005, Diabetes & metabolism.

PREPRANDIAL INTRANASAL INSULIN

V. Lassmann-Vague, B. Vialettes, P. Vague, 1988, The Lancet.

Low acute insulin response to intravenous glucose. A sensitive but non-specific marker of early stages of Type 1 (insulin-dependent) diabetes

V. Lassmann-Vague, B. Vialettes, P. Vague, 1988, Diabetologia.

Relationship between HLA‐DQ and ‐DR genotypes and clinical characteristics in a French population of Type 1 diabetic patients

V. Lassmann-Vague, B. Vialettes, P. Vague, 1999, Diabetic medicine : a journal of the British Diabetic Association.

When to treat a diabetic patient using an external insulin pump. Expert consensus. Société francophone du diabète (ex ALFEDIAM) 2009.

E. Renard, B. Guerci, M. Pinget, 2010, Diabetes & metabolism.

Pump Insulin Pump T Tr r eatment in eatment in T T ype 2 Diabetes ype 2 Diabetes

D. Owens, E. Renard, M. Massi-Benedetti, 2008 .

Access of children and adolescents with type 1 diabetes to insulin pump therapy has greatly increased in France since 2001.

B. Guerci, H. Hanaire, V. Sulmont, 2011, Diabetes & metabolism.

Effect of nicotinamide treatment on the residual insulin secretion in Type 1 (insulin-dependent) diabetic patients

V. Lassmann-Vague, B. Vialettes, P. Vague, 1989, Diabetologia.

Assessment of the level of Assessment of the level

D. Owens, E. Renard, M. Massi-Benedetti, 2007 .

Acute Insulin Response to Glucose and Glucagon in Subjects at Risk of Developing Type I Diabetes

V. Lassmann-Vague, B. Vialettes, P. Vague, 1993, Diabetes Care.

Effect of cyclosporin A on B-cell loss in Type 1 (insulin-dependent) diabetes mellitus

V. Lassmann-Vague, B. Vialettes, P. Vague, 1989, Diabetologia.

[Pregnancy and contraception in the diabetic woman. Gestational diabetes. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases)].

A. Vambergue, M. Pinget, V. Lassmann-Vague, 1996, Diabetes & metabolism.

[Unusual ways of insulin administration].

V. Lassmann-Vague, 1988, Diabete & metabolisme.

Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations.

G. Vanzetto, E. Belle, J. Monin, 2004, Diabetes & metabolism.

Alternatives routes of insulin delivery.

D. Raccah, V. Lassmann-Vague, V Lassmann-Vague, 2006, Diabetes & metabolism.

Key priorities in managing glucose control in older people with diabetes

G. Berrut, I. Bourdel-Marchasson, A. Fagot-Campagna, 2009 .

NICOTINAMIDE MAY EXTEND REMISSION PHASE ININSULIN-DEPENDENT DIABETES

V. Lassmann-Vague, B. Vialettes, P. Vague, 1987, The Lancet.

Continuous intraperitoneal insulin infusion does not increase the risk of organ-specific autoimmune disease in type 1 diabetic patients: results of a multicentric, comparative study.

H. Gin, E. Renard, P. Lejeune, 2006, Diabetes & metabolism.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Six‐year follow‐up of a cohort of 203 patients with diabetes after screening for silent myocardial ischaemia

J. Aviérinos, D. Raccah, V. Lassmann-Vague, 2006, Diabetic medicine : a journal of the British Diabetic Association.

[Inflammatory rheumatism flare-up after surgical treatment of Cushing's disease: two cases].

P. Lafforgue, D. Raccah, V. Lassmann-Vague, 1992, La Revue de medecine interne.

Stress antecedents and immune status in recently diagnosed type I (insulindependent) diabetes mellitus.

C. Farnarier, V. Lassmann-Vague, B. Vialettes, 1989, Diabete & metabolisme.

Treatment of diabetes mellitus using an external insulin pump: the state of the art.

B Guerci, E Renard, H Hanaire, 2008, Diabetes & metabolism.

The EVADIAC experience

P. Schaepelynck-Belicar, V. Lassmann-Vague, V. Lassmann-Vague, 2006 .

Local Adverse Events Associated With Long-Term Treatment by Implantable Insulin Pumps: The French EVADIAC Study Group experience

V. Lassmann-Vague, P. Belicar, 1998, Diabetes Care.

Increased prevalence of neurologic complications among insulin dependent diabetic patients of Algerian origin.

V. Lassmann-Vague, B. Vialettes, P. Vague, 1988, Diabete & metabolisme.

[History, accuracy and precision of SMBG devices].

V. Lassmann-Vague, P. Vague, L. Dufaitre-Patouraux, 2003, Diabetes & metabolism.

Improvement of HbA1c and Blood Glucose Stability in IDDM Patients Treated With Lispro Insulin Analog in External Pumps

E. Renard, J. Bringer, B. Guerci, 1998, Diabetes Care.

Insulin Kinetics in Type I Diabetic Patients Treated by Continuous Intraperitoneal Insulin Infusion: Influence of Anti‐insulin Antibodies

D. Raccah, V. Lassmann-Vague, P. Belicar, 1996, Diabetic Medicine.

[How should we use the short-acting insulin analog Lys-Pro in external continuous subcutaneous pumps?].

E. Renard, B. Guerci, N. Jeandidier, 2000, Diabetes & metabolism.

Reproducibility of plasma insulin kinetics during intraperitoneal insulin treatment by programmable pumps.

V. Lassmann-Vague, P. Vague, V Lassmann-Vague, 2003, Diabetes & metabolism.

Continuous intraperitoneal insulin infusion does not increase the risk of organ-specific autoimmune disease in type 1 diabetic patients: results of a multicentric, comparative study.

N. Jeandidier, B. Catargi, V. Melki, 2006, Diabetes & metabolism.

SHBG (sex hormone binding globulin) levels in insulin dependent diabetic patients according to the route of insulin administration.

D. Raccah, V. Lassmann-Vague, P. Belicar, 1994, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

What could be the reasons for giving up the implanted pump treatment?

P. Schaepelynck-Belicar, V. Lassmann-Vague, P Schaepelynck-Bélicar, 2005, Diabetes & metabolism.

Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS).

P. Schaepelynck-Belicar, V. Lassmann-Vague, P. Vague, 2003, Diabetes & metabolism.

Treatment of diabetes mellitus using an external insulin pump: the state of the art.

A. Vambergue, E. Renard, D. Raccah, 2008, Diabetes & metabolism.